A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis - Takeaways - MDSpire

A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis

  • By

  • Chang Cheng

  • Wei Wang

  • Tingting Zheng

  • Xiangmin Shi

  • Chong Fu

  • May 13, 2026

  • 0 min

Share

  • 1

    Geraniin is a polyphenolic compound that shows potential in mitigating ulcerative colitis in a murine model through multi-omics approaches.

  • 2

    The study identified 27 target genes for geraniin, linking them to 337 ulcerative colitis-associated genes in a protein–protein interaction network.

  • 3

    In vivo results indicated that geraniin treatment reduced disease activity index scores and improved colon length and mucosal integrity in DSS-induced UC mice.

  • 4

    Geraniin treatment was associated with a decrease in pro-inflammatory markers and an increase in anti-inflammatory macrophage markers.

  • 5

    The findings suggest that geraniin may alleviate inflammation in ulcerative colitis by modulating macrophage and neutrophil phenotypes.

Original Source(s)

A preclinical investigation into the potential associations of geraniin with ulcerative colitis alleviation through integrated multi-omics and in vivo analysis

  • by Chang Cheng, Wei Wang, Tingting Zheng, Xiangmin Shi, Chong Fu

  • May 13, 2026

Related Content

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.